Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Andrew M. Kaunitz, MD

    Article

    2016 Update on menopause

    Author:
    Andrew M. Kaunitz, MD

    Recent trial results on the cardiovascular safety of hormone therapy in early menopausal women are reassuring, while survey data reveal millions...

    • Read More

    Article

    How gynecologic procedures and pharmacologic treatments can affect the uterus

    Author:
    Michelle Stalnaker Ozcan, MD
    Andrew M. Kaunitz, MD

    Understanding and identifying possible uterine changes caused by endometrial ablation and tamoxifen use can be important for subsequent treatment...

    • Read More

    News

    Is BRCA testing causing women to undergo unnecessary prophylactic mastectomy?

    Author:
    Andrew M. Kaunitz, MD

    Yes. According to this cross-sectional analysis of an ongoing prospective cohort study of the trends in BRCA1 and BRCA2 mutation testing, 82 (51.2...

    • Read More

    News

    Can CA 125 screening reduce mortality from ovarian cancer?

    Author:
    Andrew M. Kaunitz, MD

    Yes, according to promising, but preliminary, findings from a large United Kingdom (UK) trial that demonstrated an overall average mortality...

    • Read More

    News

    No surprises from the USPSTF with new guidance on screening mammography

    Author:
    Andrew M. Kaunitz, MD

    Newly published guidelines reflect screening practices recommended by the Task Force since 2009. What is updated is their focus on more...

    • Read More

    Article

    Does the Mediterranean diet reduce the risk of breast cancer?

    Author:
    Andrew M. Kaunitz, MD

    It may.

    • Read More

    Article

    Does the discontinuation of menopausal hormone therapy affect a woman’s cardiovascular risk?

    Author:
    Andrew M. Kaunitz, MD
    Joann E. Manson, MD, DrPH
    And Cynthia A. Stuenkel, MD

    No.

    • Read More

    News

    Is a minimally invasive approach to hysterectomy for Gyn cancer utilized equally in all racial and income groups?

    Author:
    Andrew M. Kaunitz, MD

    No.

    • Read More

    News

    How to individualize cancer risk reduction after a diagnosis of DCIS

    Author:
    Laila Samiian, MD
    Andrew M. Kaunitz, MD

    With proper patient counseling and careful decision making, you can reduce the risk of recurrence and invasive disease without overtreating the...

    • Read More

    Audio

    Managing menopausal symptoms in women with a BRCA mutation

    Author:
    Andrew M. Kaunitz, MD

    Dr. Andrew Kaunitz elaborates on data, presented at NAMS 2015, regarding the use of estrogen and estrogen-progestin in women undergoing risk-...

    • Read More

    Article

    Imaging the suspected ovarian malignancy: 14 cases

    Author:
    Michelle Stalnaker Ozcan, MD
    Andrew M. Kaunitz, MD

    The presented cases demonstrate transvaginal ultrasonography, as well as intraoperative imaging, of cystadenoma, low malignant potential tumors,...

    • Read More

    Article

    Which vaginal procedure is best for uterine prolapse?

    Author:
    Meadow M. Good, DO
    Andrew M. Kaunitz, MD

    Sacrospinous hysteropexy and vaginal hysterectomy with uterosacral ligament suspension were found to be comparable at 12 months after surgery in...

    • Read More

    News

    Does the injection of ketorolac prior to IUD placement reduce pain?

    Author:
    Andrew M. Kaunitz, MD

    It reduces postinsertion pain but not the pain associated with placement, according to this randomized, double-blind, placebo-controlled...

    • Read More

    News

    “Cogwheel” and other signs of hydrosalpinx and pelvic inclusion cysts

    Author:
    Michelle Stalnaker Ozcan, MD
    Andrew M. Kaunitz, MD

    These types of cysts do not require further imaging if diagnosis is certain. When can you be confident with the final diagnosis? These authors...

    • Read More

    Article

    Is menopausal hormone therapy safe when your patient carries a BRCA mutation?

    Author:
    Andrew M. Kaunitz, MD

    Data suggest that several years of systemic hormone therapy are safe in mutation carriers who have intact breasts and no personal history of...

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery